Intravenous Antibiotic Treatment at Home

NCT04898452 | Recruiting

• 1 other identifier: 2019/60
• Study Type: observational
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of the study is to develop and evaluate a new model for across services interaction with the use of welfare technology and telemedicine. The model includes innovative and new routines for the exchange of patient information, quality systems and procedures between the municipality and the hospital. This model will first be tested for use in intravenous antibiotic therapy. The results of the study will be used to further develop the service. In the larger context, it is desirable to provide knowledge that is transferable to other diagnostic groups, treatment methods and geographical areas.

Conditions

Infection

Keywords

Home Care Services, Hospital-Based; Telemedicine; Home Infusion Therapy; Hospital at home; Antibiotics

Outcome Measures

Primary Outcomes (3)

• number of rehospitalisations

  45 months

• patient satisfaction

  assessed with semi-structured interview

  45 months

• health personnel's opinion on patient safety

  based on answers in web-case-registration-form (CRF)

  45 months

Study Arms (3)

Patients needing antibiotics infusion

Patients needing antibiotics infusion A new model of interaction across health services with use of welfare technology and telemedicine Instead of admitted to the hospital, patients are followed up at home by the municipal regional response center and nurses in the response team according to the individual treatment plan. Hospital physicians are medically responsible throughout the course.

Other: A new model of interaction across health services with use of welfare technology and telemedicine

Next of kin

Next of kin A new model of interaction across health services with use of welfare technology and telemedicine Instead of admitted to the hospital, patients are followed up at home by the municipal regional response center and nurses in the response team according to the individual treatment plan. Hospital physicians are medically responsible throughout the course.

Other: A new model of interaction across health services with use of welfare technology and telemedicine

Health professionals

A new model of interaction across health services with use of welfare technology and telemedicine Instead of admitted to the hospital, patients are followed up at home by the municipal regional response center and nurses in the response team according to the individual treatment plan. Hospital physicians are medically responsible throughout the course.

Other: A new model of interaction across health services with use of welfare technology and telemedicine

Interventions

A new model of interaction across health services with use of welfare technology and telemedicine OTHER

Instead of admitted to the hospital, patients are followed up at home by the municipal regional response center and nurses in the response team according to the individual treatment plan. Hospital physicians are medically responsible throughout the course.

Health professionals; Next of kin; Patients needing antibiotics infusion

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients participate in both study part 1 (qualitative) and study part 2 (quantitative). Health professionals and next to kins participate in study part 1 (qualitative).

You may qualify if:

• Main or bi-diagnosis during stay:
• A692 Borreliosis G00 - G009 Central nervous system inflammatory disorders I33 Endocarditis J86 Empyema D46.3 Spondylodiscitis M86 Osteomyelitis T84 Prosthesis / osteosynthesis infections M00.0-M00.9 Pyogen / septic arthritis J40-J47 Chronic diseases of the lower respiratory tract
• Competent to give consent
• The infection can not be treated with oral antibiotics in monotherapy
• Selected IV antibiotics must be suitable for administration via selected pumps
• The patient's condition is stable and does not require frequent observation by health care professionals
• The patient is motivated and willing to participate in intravenous treatment in home hospitals
• Must, after training, demonstrate mastery of practical procedures related to pump handling and any other procedures described in the patient's treatment plan
• The home must be suitable for intravenous antibiotic treatment; access to refrigerators, hygienic conditions, social conditions
• The patient must have a mobile phone and be able to handle the system for fast and secure communication with the Regional Response Center (RRO)

You may not qualify if:

• consent not given

Sponsors & Collaborators

• Helse Møre og Romsdal HF: lead
• SINTEF Health Research: collaborator
• Kristiansund municipality: collaborator
• Centre for Health Innovation: collaborator
• Hospital Pharmacy of Central Norway Trust: collaborator

Study Sites (1)

Helse Møre og Romsdal HF, Kristiansund sjukehus, Medisinsk Avdeling

Kristiansund, Norway

RECRUITING

MeSH Terms

Conditions

Infections

Interventions

Telemedicine

Intervention Hierarchy (Ancestors)

Delivery of Health Care; Patient Care Management; Health Services Administration

Study Officials

• Torstein Hole, md phd

  Møre og Romsdal Hospital Trust

  STUDY DIRECTOR

Central Study Contacts

Inger Stokke, MSc

CONTACT

+47 41928023; inger.stokke@helse-mr.no

Ann Iren Kjønnøy, MSc

CONTACT

Ann.Iren.Kjonnoy@helse-mr.no

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER GOV
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 1, 2020
• First Posted: May 24, 2021
• Study Start: July 2, 2020
• Primary Completion: December 31, 2025
• Study Completion (Estimated): December 31, 2026
• Last Updated: June 22, 2025

Record last verified: 2025-06

Locations

NO (1)